/Investor DB

XT Hi-Tech — Full Portfolio

5 tracked investments · listed companies and verified rows first

CardinalOpscardinalops.cominSeries A · Mar 2022 · $18MAcquired

CardinalOps offers an AI-driven detection engineering platform that analyzes an organization's SIEM and EDR tools to identify coverage gaps, fix broken or noisy detection rules, and generate new threat-informed detections mapped to the MITRE ATT&CK framework.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaSBoston, US

Michael Mumcuoglu(Co-Founder & CEO)inYair Manor(Co-Founder & CTO)inAdi Sapir(CFO)in

Co-investorsBattery VenturesIN VentureViola VenturesGlilot Capital PartnersRepsol Energy VenturesSymbol+3 more

Epitomeeepitomeecapsule.comApr 2019 · $8M

Epitomee Medical develops the Epitomee Capsule, a medical device for weight management solutions.

HealthtechMedical DevicesWellness & Fitness

Co-investorsAgate Medical Investments LP

Localbirdlocalbird.ioinOct 2024

Localbird enables short-term rental hosts to monetize local expertise by sharing insider recommendations and experiences with guests.

Direct to ConsumerMarketplacesPropTechTravel & Hospitality

Ben Levy(CEO and Co-founder)inJoseph Levy(Co-founder)in

Co-investorsIbex InvestorsRUNI VenturesXT Venture CapitalPitangoState of Mind Ventures

NeuRealityneureality.aiin𝕏Dec 2022

NeuReality builds software and networking infrastructure that helps AI teams improve GPU and XPU utilization, throughput, and cost per token for production AI inference.

AI & Machine LearningData & InfrastructureSemiconductors

Moshe Tanach(Co-founder & CEO)inTzvika Shmueli(Co-Founder & COO)inYossi Kasus(Co-Founder & VP VLSI)inLior Khermosh(CTO)inItay Avilevich(VP R&D)inGaurav Shah(VP Business Development)in

Co-investorsCardumen CapitalCleveland AvenueGefen CapitalMarketX VenturesOurCrowdVarana+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BioT Medical

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.